CoChat

TANK-binding kinase 1 as a novel therapeutic target for viral diseases

Zhao, Chunyuan, Zhao, Wei · 2019 · Expert Opinion on Therapeutic Targets

The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: TANK-binding kinase 1 (TBK1) is vital for the induction of antiviral innate immune responses. Both RNA and DNA viral infection induces TBK1 activation, triggers phosphorylation of interferon regulatory factor (IRF) 3 and subsequent expression of type I interferons (IFNs; IFN-α/β). Type I IFNs can induce the expression of numerous antiviral genes called interferon-stimulated genes (ISGs) to build a remarkable antiviral state and limit viral replication. Thus, optimal TBK1 activity is crucial for IRF3-induced type I IFNs expression and ISGs-mediated viral elimination. Areas covered: This review provides an overview of the diverse roles of TBK1 in antiviral innate immune responses, the regulatory mechanisms of TBK1 activity and the implication in antiviral development. Expert opinion: TBK1 is a key kinase against antiviral infection via inducing type I IFNs expression. Multiple types of post-translational modifications of TBK1 tightly regulate TBK1 activity and subsequent TBK1-dependent antiviral responses. The identified regulators of TBK1 unveil regulatory mechanisms of host antiviral innate immunity and immuno-escape mechanism of virus provide strategies to control viral diseases by modulating TBK1 activity.

Overview

Integrity signals

Registry

Crossref · 10.1080/14728222.2019.1601702

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 119 references

Research works printed but not linked: 3

  1. Li X, 2017, Sci Signal, 10
  2. Rezelj VV, 2017, mSphere, 2:e00234-17
  3. Liu X, 2018, J Virol, 92

Cited by

See all 61

Metadata

Authors
Zhao, C., & Zhao, W.
Affiliations
Shandong University (CN)
Corresponding author
Zhao, Wei
Venue
Expert Opinion on Therapeutic Targets
Published
2019-04-10
Volume
23
Issue
5
Pages
437-446
ISSN
  • 1472-8222 (ISSN-L)
  • 1744-7631
OpenAlex
W2932181568
Cited by
61
References
119
Citations by year
2026: 1 · 2025: 5 · 2024: 15 · 2023: 10 · 2022: 10 · 2021: 12 · 2020: 8
FWCI
2.99
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Therapeutic Targets (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • the National Natural Science Foundation of China (81622030)
  • the Fundamental Research Funds of Shandong University (2016JC023)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords
TBK1, antiviral innate immunity, type I interferon, IRF3, interferon-stimulated genes, post-translational modification, viral immune evasion, antiviral drug targets
MeSH terms
Drug Development, Animals, Antiviral Agents, Humans, Immunity, Innate, Interferon Type I, Virus Diseases, Virus Replication, Protein Serine-Threonine Kinases, Interferon Regulatory Factor-3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TANK-binding kinase 1 as a novel therapeutic target for viral diseases. https://app.cochat.ai/papers/10.1080/14728222.2019.1601702
The paper
Zhao, C., & Zhao, W. (2019). TANK-binding kinase 1 as a novel therapeutic target for viral diseases. Expert Opinion on Therapeutic Targets. https://doi.org/10.1080/14728222.2019.1601702

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.